MT-1002(Navidea Biopharmaceuticals)

N/A

Report date: 2024/07/31 10:49:04

Base Information

Drug NameMT-1002(Navidea Biopharmaceuticals)
Drug Alias NameMT-1002(Macrophage Therapeutics)MT-1002
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsZika Virus InfectionDengueLeishmaniasis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNavidea Biopharmaceuticals IncMacrophage Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavidea Biopharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsZika Virus InfectionDengueLeishmaniasis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A